Sensus Healthcare, Inc. (SRTS) – Corporate News
-
Sensus Healthcare's (SRTS) SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients
-
Sensus Healthcare (SRTS) Reports Prelim Q3 Revenue of Over $13M
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRTS Stock Lookup